Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cellectis Share Issue/Capital Change 2023

Dec 1, 2023

1190_dva_2023-12-01_1ba969da-01d1-44f0-b5c3-725e24d265b8.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Monthly information on share capital and company voting rights

(Article 223-16 of General Regulation of the French financial markets authority)

Listing market: Euronext Growth

ISIN code: FR0010425595

Date Total number of shares
in the capital
Total number of voting
rights
11/30/2023 71,751,201 77,686,109

For further information on Cellectis, please contact:

Media contact:

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93, [email protected]

Investor Relations contacts:

Arthur Stril, Chief Business Officer, +1 (347) 809 5980, [email protected]

Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577